International consensus statement on allergy and rhinology: Allergic rhinitis–2023
Background In the 5 years that have passed since the publication of the 2018 International
Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (ICAR‐Allergic Rhinitis …
Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (ICAR‐Allergic Rhinitis …
Review of rhinitis: classification, types, pathophysiology
GA Liva, AD Karatzanis, EP Prokopakis - Journal of clinical medicine, 2021 - mdpi.com
Rhinitis describes a pattern of symptoms as a result of nasal inflammation and/or dysfunction
of the nasal mucosa. It is an umbrella entity that includes many different subtypes, several of …
of the nasal mucosa. It is an umbrella entity that includes many different subtypes, several of …
Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
JB Soriano, PJ Kendrick, KR Paulson… - The Lancet …, 2020 - thelancet.com
Background Previous attempts to characterise the burden of chronic respiratory diseases
have focused only on specific disease conditions, such as chronic obstructive pulmonary …
have focused only on specific disease conditions, such as chronic obstructive pulmonary …
Allergic rhinitis
Allergic rhinitis (AR) is caused by immunoglobulin E (IgE)-mediated reactions to inhaled
allergens and is one of the most common chronic conditions globally. AR often co-occurs …
allergens and is one of the most common chronic conditions globally. AR often co-occurs …
ARIA guideline 2019: treatment of allergic rhinitis in the German health system
L Klimek, C Bachert, O Pfaar, S Becker, T Bieber… - Allergo journal …, 2019 - Springer
Background The number of patients affected by allergies is increasing worldwide. The
resulting allergic diseases are leading to significant costs for health care and social systems …
resulting allergic diseases are leading to significant costs for health care and social systems …
Development and validation of combined symptom‐medication scores for allergic rhinitis
Background Validated combined symptom‐medication scores (CSMSs) are needed to
investigate the effects of allergic rhinitis treatments. This study aimed to use real‐life data …
investigate the effects of allergic rhinitis treatments. This study aimed to use real‐life data …
ARIA digital anamorphosis: digital transformation of health and care in airway diseases from research to practice
Digital anamorphosis is used to define a distorted image of health and care that may be
viewed correctly using digital tools and strategies. MASK digital anamorphosis represents …
viewed correctly using digital tools and strategies. MASK digital anamorphosis represents …
Differentiation of COVID‐19 signs and symptoms from allergic rhinitis and common cold: An ARIA‐EAACI‐GA2LEN consensus
Background Although there are many asymptomatic patients, one of the problems of COVID‐
19 is early recognition of the disease. COVID‐19 symptoms are polymorphic and may …
19 is early recognition of the disease. COVID‐19 symptoms are polymorphic and may …
Validity, reliability, and responsiveness of daily monitoring visual analog scales in MASK‐air®
B Sousa‐Pinto, P Eklund, O Pfaar… - Clinical and …, 2021 - Wiley Online Library
Background MASK‐air® is an app that supports allergic rhinitis patients in disease control.
Users register daily allergy symptoms and their impact on activities using visual analog …
Users register daily allergy symptoms and their impact on activities using visual analog …
Digitally‐enabled, patient‐centred care in rhinitis and asthma multimorbidity: The ARIA‐MASK‐air® approach
MASK‐air®, a validated mHealth app (Medical Device regulation Class IIa) has enabled
large observational implementation studies in over 58,000 people with allergic rhinitis …
large observational implementation studies in over 58,000 people with allergic rhinitis …